Cooperation of Oncolytic Herpes Virotherapy and PD-1 Blockade in Murine Rhabdomyosarcoma Models
Abstract Oncolytic virotherapy is an effective immunotherapeutic approach for cancer treatment via a multistep process including direct tumor cell lysis, induction of cytotoxic or apoptosis-sensitizing cytokines and promotion of antitumor T cell responses. Solid tumors limit the effectiveness of imm...
Guardado en:
Autores principales: | Chun-Yu Chen, Pin-Yi Wang, Brian Hutzen, Les Sprague, Hayley M. Swain, Julia K. Love, Joseph R. Stanek, Louis Boon, Joe Conner, Timothy P. Cripe |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fdcd41e11f1d41dba014f2f0f98645df |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
- Oncolytic Virotherapy
-
Oncolytic Virotherapy
Publicado: (2016) -
Oncolytic Virotherapy: From Bench to Bedside
por: Ludi Yang, et al.
Publicado: (2021) -
Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination
por: D. G. Roy, et al.
Publicado: (2021) -
Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy
por: Timothy Kottke, et al.
Publicado: (2021)